How much cash does ArriVent BioPharma, Inc. generate?

ArriVent BioPharma, Inc. (AVBP) generated -$134.5M in operating cash flow over the trailing twelve months.

Where does ArriVent BioPharma, Inc.'s cash flow data come from?

Every line is extracted from ArriVent BioPharma, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

ArriVent BioPharma, Inc. AVBP Cash Flow Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Net income	-$145.24M+12.7%	-$166.31M-9.8%	-$151.4M-10.5%	-$136.98M-7.5%	-$127.46M-58.4%
Depreciation and amortization	-$2.83M+6.5%	-$3.03M—	——	——	——
Stock-based compensation	$15.73M+25.7%	$12.52M+22.1%	$10.25M+38.5%	$7.4M+52.5%	$4.85M+51.3%
Net cash from operating activities	-$134.47M+16.3%	-$160.59M-9.9%	-$146.08M-15.4%	-$126.63M-5.9%	-$119.59M-70.3%
Net cash from investing activities	-$104.47M-46.7%	-$71.23M-47.9%	-$48.15M-5.8%	-$45.5M+57.7%	-$107.53M+44.1%
Net cash from financing activities	$251.18M+23.7%	$203.06M+20.6%	$168.39M+104%	$82.46M+970%	$7.71M-95.9%
Net increase (decrease) in cash	$12.24M+143%	-$28.75M+83.1%	-$170.18M—	——	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does ArriVent BioPharma, Inc. generate?: ArriVent BioPharma, Inc. (AVBP) generated -$134.5M in operating cash flow over the trailing twelve months.
Where does ArriVent BioPharma, Inc.'s cash flow data come from?: Every line is extracted from ArriVent BioPharma, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.